Impaired leucocyte activation is underlining the lower thrombotic risk of essential thrombocythaemia patients with CALR mutations as compared with those with the JAK2 mutation.
In: British Journal of Haematology, Jg. 172 (2016-03-01), Heft 5, S. 813-815
academicJournal
Zugriff:
The article discusses the study on impaired leucocyte activation in patients with essential thrombocythaemia (ET) who carry mutations in JAK2 V617F gene, calreticulin, and codon 515 thrombopoietin receptor gene. The study reportedly involved several ET patients in Murcia, Spain from 1990 to 2006. The results revealed that impaired leucocyte activation underlines lower thrombotic risk.
Titel: |
Impaired leucocyte activation is underlining the lower thrombotic risk of essential thrombocythaemia patients with CALR mutations as compared with those with the JAK2 mutation.
|
---|---|
Autor/in / Beteiligte Person: | Torregrosa, Jose M. ; Ferrer‐Marín, Francisca ; Lozano, María L. ; Moreno, Maria J. ; Martinez, Constantino ; Anton, Ana I. ; Rivera, José ; Vicente, Vicente |
Zeitschrift: | British Journal of Haematology, Jg. 172 (2016-03-01), Heft 5, S. 813-815 |
Veröffentlichung: | 2016 |
Medientyp: | academicJournal |
ISSN: | 0007-1048 (print) |
DOI: | 10.1111/bjh.13539 |
Schlagwort: |
|
Sonstiges: |
|